Patents

US 12582647 B2: Systems and methods for treating an opioid-induced adverse pharmacodynamic response

Granted
2026-03-24
Filed
2024-02-08 application 18436555
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.

Source: PTBLXML, file of 2026-03-24 (ipgb20260324.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
PURDUE PHARMA L.P. 482 patentsUS company or organizationStamford, CTPURDUE PHARMA L.P. State business registration EXACT high confidence: identical full name and statePTBLXML, file of 2026-03-24

Inventors

InventorPlacePatentsPerson pageSource
Michele HummelMarlton, NJ13PTBLXML, file of 2026-03-24
Donald J. KyleYardley, PA60PTBLXML, file of 2026-03-24
Garth WhitesideYardley, PA19PTBLXML, file of 2026-03-24

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/485PTBLXML, file of 2026-03-24

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.